The full invitation to the AGM 2025 may be found in the General Meetings section of the Company's website here.

Researchers from the University of Rochester and University of California, Santa Barbara, engineered a laser device smaller ...

Robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms – – Generally ...

A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

Commercialization has started for network switches based on co-packaged optics (CPO), which are capable of routing signals at terabits per second speeds, but manufacturing challenges remain regarding ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Duke scientists may have discovered a game-changing painkiller. SBI-810 is a new non-opioid drug that offers potent pain ...

Phase 2a trial of RAP-219 in refractory focal epilepsy fully enrolled and on track for topline results in September ...